RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm

dc.contributor.authorKok, C.H.
dc.contributor.authorAl-Kali, A.
dc.contributor.authorThomas, D.
dc.contributor.authorHe, R.
dc.contributor.authorKutyna, M.M.
dc.contributor.authorAlkhateeb, H.B.
dc.contributor.authorLim, K.
dc.contributor.authorSaliba, A.N.
dc.contributor.authorToop, C.
dc.contributor.authorMatin, A.
dc.contributor.authorScott, H.S.
dc.contributor.authorGangat, N.
dc.contributor.authorBrown, A.L.
dc.contributor.authorMangaonkar, A.A.
dc.contributor.authorHahn, C.N.
dc.contributor.authorBegna, K.
dc.contributor.authorHung, K.
dc.contributor.authorGreipp, P.T.
dc.contributor.authorHogan, W.J.
dc.contributor.authorPatnaik, M.M.
dc.contributor.authoret al.
dc.date.issued2025
dc.descriptionResearch Letter
dc.description.abstractAbstract not available.
dc.description.statementofresponsibilityChung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal Patnaik, Mithun Shah, and Devendra K. Hiwase
dc.identifier.citationBlood advances, 2025; 9(15):3814-3818
dc.identifier.doi10.1182/bloodadvances.2025016374
dc.identifier.issn2473-9529
dc.identifier.issn2473-9537
dc.identifier.orcidKok, C.H. [0000-0002-3181-7852]
dc.identifier.orcidKutyna, M.M. [0000-0003-2315-091X]
dc.identifier.orcidLim, K. [0000-0003-4606-7588]
dc.identifier.orcidScott, H.S. [0000-0002-5813-631X]
dc.identifier.orcidBrown, A.L. [0000-0002-9023-0138]
dc.identifier.orcidHahn, C.N. [0000-0001-5105-2554]
dc.identifier.orcidHiwase, D.K. [0000-0002-6666-3056]
dc.identifier.urihttps://hdl.handle.net/2440/147791
dc.language.isoen
dc.publisherElsevier
dc.relation.grantNHMRC
dc.rights© 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
dc.source.urihttps://doi.org/10.1182/bloodadvances.2025016374
dc.subjectRAS mutation; therapy-related myeloid neoplasm
dc.titleRAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm
dc.typeJournal article
pubs.publication-statusPublished online

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_147791.pdf
Size:
249.23 KB
Format:
Adobe Portable Document Format
Description:
Published version

Collections